Study Examines Malpractice Litigation in Peds Ophthalmology

This article originally appeared here.
Share this content:
Study Examines Malpractice Litigation in Peds Ophthalmology
Study Examines Malpractice Litigation in Peds Ophthalmology

TUESDAY, Sept. 6, 2016 (HealthDay News) -- In ophthalmology medical malpractice litigation, cases involving pediatric versus adult patients are more likely to result in verdicts in favor of the plaintiff and have higher jury awards and indemnity payments, according to a study published online Sept. 1 in JAMA Ophthalmology.

Stephanie B. Engelhard, from the University of Virginia in Charlottesville, and colleagues examined the causes and outcomes of ophthalmology medical malpractice litigation involving pediatric patients. The study included 68 ophthalmology malpractice cases involving plaintiffs younger than 18 years.

The researchers found that 51.5 percent of cases were resolved via jury trial. Of these, 48.6 percent had verdicts that were issued in favor of the plaintiff, compared with 28.8 percent in adult cases (P = 0.01). Of the verdicts in favor of the pediatric plaintiff, the mean injury award was $4,815,693. Overall, a total of 13.2 percent of cases resulted in a settlement, with mean adjusted indemnities of $1,912,738. In pediatric versus adult cases, jury awards were higher (P = 0.002), as were indemnity payments (P = 0.003). Verdicts in favor of the plaintiff were more likely in cases involving legal blindness (P = 0.30). In cases of litigation, common clinical scenarios included traumatic ocular injury, retinopathy of prematurity, and endophthalmitis.

"This information may give pediatric ophthalmologists insight into the situations and conditions that commonly lead to litigation," the authors write.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

FDA Warns of Possible Heart Risks Linked to Clarithromycin

FDA Warns of Possible Heart Risks Linked to ...

Agency advising doctors to consider prescribing other antibiotics to patients with coronary heart disease

Artificial Intelligence May Help Prevent Physician Burnout

Artificial Intelligence May Help Prevent Physician Burnout

Many potential uses for AI, including improving searches and documentation, selecting treatment

Benzodiazepine Use Declining in Older Adults

Benzodiazepine Use Declining in Older Adults

Findings based on assessment of incidence, prevalence of use in three countries from 2010-2016

is free, fast, and customized just for you!

Already a member?

Sign In Now »